nodes	percent_of_prediction	percent_of_DWPC	metapath
Framycetin—CXCR4—Binding and entry of HIV virion—CCR5—atopic dermatitis	0.0404	0.107	CbGpPWpGaD
Framycetin—Secondary infection—Desonide—atopic dermatitis	0.026	0.0419	CcSEcCtD
Framycetin—CXCR4—Binding and entry of HIV virion—CD4—atopic dermatitis	0.0254	0.0669	CbGpPWpGaD
Framycetin—Posterior subcapsular cataract—Fluocinolone Acetonide—atopic dermatitis	0.025	0.0402	CcSEcCtD
Framycetin—Cataract subcapsular—Fluocinonide—atopic dermatitis	0.0237	0.0382	CcSEcCtD
Framycetin—Secondary infection—Fluocinonide—atopic dermatitis	0.021	0.0339	CcSEcCtD
Framycetin—Nerve injury—Fluocinolone Acetonide—atopic dermatitis	0.0177	0.0285	CcSEcCtD
Framycetin—Eye infection—Pimecrolimus—atopic dermatitis	0.0174	0.028	CcSEcCtD
Framycetin—CXCR4—Chemokine receptors bind chemokines—CCL22—atopic dermatitis	0.017	0.0448	CbGpPWpGaD
Framycetin—Ulcerative keratitis—Fluocinolone Acetonide—atopic dermatitis	0.0153	0.0246	CcSEcCtD
Framycetin—CXCR4—Chemokine receptors bind chemokines—CCL27—atopic dermatitis	0.0152	0.04	CbGpPWpGaD
Framycetin—Sensitisation—Pimecrolimus—atopic dermatitis	0.0151	0.0243	CcSEcCtD
Framycetin—CXCR4—Early Phase of HIV Life Cycle—CCR5—atopic dermatitis	0.0148	0.0391	CbGpPWpGaD
Framycetin—Cataract subcapsular—Fluocinolone Acetonide—atopic dermatitis	0.0148	0.0238	CcSEcCtD
Framycetin—CXCR4—Chemokine receptors bind chemokines—CCL17—atopic dermatitis	0.0136	0.0358	CbGpPWpGaD
Framycetin—Nerve injury—Tacrolimus—atopic dermatitis	0.0134	0.0217	CcSEcCtD
Framycetin—Secondary infection—Fluocinolone Acetonide—atopic dermatitis	0.0131	0.0212	CcSEcCtD
Framycetin—Secondary infection—Mometasone—atopic dermatitis	0.0125	0.0202	CcSEcCtD
Framycetin—Eye infection—Fluocinolone Acetonide—atopic dermatitis	0.0125	0.0201	CcSEcCtD
Framycetin—Posterior subcapsular cataract—Prednisolone—atopic dermatitis	0.0121	0.0195	CcSEcCtD
Framycetin—CXCR4—Chemokine receptors bind chemokines—CCL11—atopic dermatitis	0.011	0.0289	CbGpPWpGaD
Framycetin—Sensitisation—Mometasone—atopic dermatitis	0.0103	0.0166	CcSEcCtD
Framycetin—Posterior subcapsular cataract—Betamethasone—atopic dermatitis	0.0101	0.0163	CcSEcCtD
Framycetin—Posterior subcapsular cataract—Dexamethasone—atopic dermatitis	0.0101	0.0163	CcSEcCtD
Framycetin—CXCR4—Hematopoietic Stem Cell Differentiation—IL5—atopic dermatitis	0.00969	0.0255	CbGpPWpGaD
Framycetin—CXCR4—Early Phase of HIV Life Cycle—CD4—atopic dermatitis	0.00932	0.0246	CbGpPWpGaD
Framycetin—Nephrotoxicity—Tacrolimus—atopic dermatitis	0.00923	0.0149	CcSEcCtD
Framycetin—CXCR4—Chemokine receptors bind chemokines—CCR3—atopic dermatitis	0.00894	0.0236	CbGpPWpGaD
Framycetin—Impaired healing—Fluocinolone Acetonide—atopic dermatitis	0.00893	0.0144	CcSEcCtD
Framycetin—Nerve injury—Prednisolone—atopic dermatitis	0.00858	0.0138	CcSEcCtD
Framycetin—Impaired healing—Mometasone—atopic dermatitis	0.00852	0.0137	CcSEcCtD
Framycetin—CXCR4—Syndecan-4-mediated signaling events—CCL5—atopic dermatitis	0.0085	0.0224	CbGpPWpGaD
Framycetin—Viral infection—Desonide—atopic dermatitis	0.00845	0.0136	CcSEcCtD
Framycetin—CXCR4—Chemokine receptors bind chemokines—CXCR3—atopic dermatitis	0.00781	0.0206	CbGpPWpGaD
Framycetin—Ulcerative keratitis—Prednisolone—atopic dermatitis	0.00742	0.012	CcSEcCtD
Framycetin—Cataract subcapsular—Prednisolone—atopic dermatitis	0.00718	0.0116	CcSEcCtD
Framycetin—Nerve injury—Dexamethasone—atopic dermatitis	0.00716	0.0115	CcSEcCtD
Framycetin—Nerve injury—Betamethasone—atopic dermatitis	0.00716	0.0115	CcSEcCtD
Framycetin—CXCR4—Peptide GPCRs—CCR3—atopic dermatitis	0.00715	0.0188	CbGpPWpGaD
Framycetin—Cataract subcapsular—Hydrocortisone—atopic dermatitis	0.00701	0.0113	CcSEcCtD
Framycetin—Impaired healing—Tacrolimus—atopic dermatitis	0.00678	0.0109	CcSEcCtD
Framycetin—Cataract subcapsular—Triamcinolone—atopic dermatitis	0.0066	0.0106	CcSEcCtD
Framycetin—Cataract subcapsular—Methylprednisolone—atopic dermatitis	0.00659	0.0106	CcSEcCtD
Framycetin—CXCR4—Peptide ligand-binding receptors—CCL22—atopic dermatitis	0.0064	0.0169	CbGpPWpGaD
Framycetin—CXCR4—Chemokine receptors bind chemokines—CXCL10—atopic dermatitis	0.00631	0.0166	CbGpPWpGaD
Framycetin—CXCR4—Peptide GPCRs—CXCR3—atopic dermatitis	0.00625	0.0165	CbGpPWpGaD
Framycetin—Nerve injury—Prednisone—atopic dermatitis	0.00624	0.0101	CcSEcCtD
Framycetin—Secondary infection—Hydrocortisone—atopic dermatitis	0.00623	0.01	CcSEcCtD
Framycetin—Eye infection—Prednisolone—atopic dermatitis	0.00605	0.00974	CcSEcCtD
Framycetin—Cataract subcapsular—Betamethasone—atopic dermatitis	0.00599	0.00965	CcSEcCtD
Framycetin—Cataract subcapsular—Dexamethasone—atopic dermatitis	0.00599	0.00965	CcSEcCtD
Framycetin—Viral infection—Pimecrolimus—atopic dermatitis	0.00597	0.00962	CcSEcCtD
Framycetin—Secondary infection—Triamcinolone—atopic dermatitis	0.00586	0.00945	CcSEcCtD
Framycetin—Secondary infection—Methylprednisolone—atopic dermatitis	0.00585	0.00943	CcSEcCtD
Framycetin—CXCR4—Peptide ligand-binding receptors—CCL27—atopic dermatitis	0.00571	0.015	CbGpPWpGaD
Framycetin—CXCR4—Chemokine receptors bind chemokines—CCL5—atopic dermatitis	0.00543	0.0143	CbGpPWpGaD
Framycetin—Ulcerative keratitis—Prednisone—atopic dermatitis	0.00539	0.00869	CcSEcCtD
Framycetin—Secondary infection—Betamethasone—atopic dermatitis	0.00532	0.00857	CcSEcCtD
Framycetin—Secondary infection—Dexamethasone—atopic dermatitis	0.00532	0.00857	CcSEcCtD
Framycetin—Cataract subcapsular—Prednisone—atopic dermatitis	0.00522	0.00841	CcSEcCtD
Framycetin—Glaucoma—Fluocinolone Acetonide—atopic dermatitis	0.00513	0.00826	CcSEcCtD
Framycetin—CXCR4—Peptide ligand-binding receptors—CCL17—atopic dermatitis	0.00512	0.0135	CbGpPWpGaD
Framycetin—Nephropathy toxic—Tacrolimus—atopic dermatitis	0.00511	0.00823	CcSEcCtD
Framycetin—Swelling—Fluocinonide—atopic dermatitis	0.00509	0.0082	CcSEcCtD
Framycetin—Eye infection—Betamethasone—atopic dermatitis	0.00504	0.00813	CcSEcCtD
Framycetin—Eye infection—Dexamethasone—atopic dermatitis	0.00504	0.00813	CcSEcCtD
Framycetin—Glaucoma—Mometasone—atopic dermatitis	0.0049	0.00789	CcSEcCtD
Framycetin—CXCR4—Chemokine receptors bind chemokines—CCR5—atopic dermatitis	0.0049	0.0129	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—CCL27—atopic dermatitis	0.00481	0.0127	CbGpPWpGaD
Framycetin—Viral infection—Loratadine—atopic dermatitis	0.00476	0.00766	CcSEcCtD
Framycetin—Swelling—Pimecrolimus—atopic dermatitis	0.00444	0.00715	CcSEcCtD
Framycetin—Impaired healing—Prednisolone—atopic dermatitis	0.00433	0.00698	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.00429	0.0113	CbGpPWpGaD
Framycetin—Viral infection—Fluocinolone Acetonide—atopic dermatitis	0.00427	0.00689	CcSEcCtD
Framycetin—Impaired healing—Hydrocortisone—atopic dermatitis	0.00423	0.00682	CcSEcCtD
Framycetin—CXCR4—Peptide ligand-binding receptors—CCL11—atopic dermatitis	0.00412	0.0109	CbGpPWpGaD
Framycetin—Viral infection—Mometasone—atopic dermatitis	0.00408	0.00658	CcSEcCtD
Framycetin—Impaired healing—Triamcinolone—atopic dermatitis	0.00399	0.00642	CcSEcCtD
Framycetin—Impaired healing—Methylprednisolone—atopic dermatitis	0.00398	0.00641	CcSEcCtD
Framycetin—CXCR4—Peptide GPCRs—CCR5—atopic dermatitis	0.00392	0.0103	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.00383	0.0101	CbGpPWpGaD
Framycetin—CXCR4—Hematopoietic Stem Cell Differentiation—IL1B—atopic dermatitis	0.00372	0.0098	CbGpPWpGaD
Framycetin—Impaired healing—Dexamethasone—atopic dermatitis	0.00362	0.00583	CcSEcCtD
Framycetin—Impaired healing—Betamethasone—atopic dermatitis	0.00362	0.00583	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.00343	0.00905	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—CCR3—atopic dermatitis	0.00336	0.00886	CbGpPWpGaD
Framycetin—Erythema—Desonide—atopic dermatitis	0.00334	0.00538	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—CCL22—atopic dermatitis	0.00327	0.00862	CbGpPWpGaD
Framycetin—Impaired healing—Prednisone—atopic dermatitis	0.00315	0.00507	CcSEcCtD
Framycetin—CXCR4—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.003	0.0079	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.003	0.0079	CbGpPWpGaD
Framycetin—CXCR4—Chemokine receptors bind chemokines—CXCL8—atopic dermatitis	0.00296	0.0078	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.00294	0.00775	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CCL27—atopic dermatitis	0.00291	0.00768	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—CCR3—atopic dermatitis	0.00284	0.00748	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00277	0.00729	CbGpPWpGaD
Framycetin—Infection—Desonide—atopic dermatitis	0.00271	0.00436	CcSEcCtD
Framycetin—Erythema—Fluocinonide—atopic dermatitis	0.0027	0.00436	CcSEcCtD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.00263	0.00694	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CCL17—atopic dermatitis	0.00261	0.00689	CbGpPWpGaD
Framycetin—Glaucoma—Prednisolone—atopic dermatitis	0.00249	0.00401	CcSEcCtD
Framycetin—CXCR4—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.00248	0.00654	CbGpPWpGaD
Framycetin—Glaucoma—Hydrocortisone—atopic dermatitis	0.00243	0.00392	CcSEcCtD
Framycetin—CXCR4—HIV Life Cycle—CCR5—atopic dermatitis	0.00241	0.00635	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.00238	0.00626	CbGpPWpGaD
Framycetin—Erythema—Pimecrolimus—atopic dermatitis	0.00236	0.0038	CcSEcCtD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.0023	0.00606	CbGpPWpGaD
Framycetin—Glaucoma—Triamcinolone—atopic dermatitis	0.00229	0.00369	CcSEcCtD
Framycetin—Glaucoma—Methylprednisolone—atopic dermatitis	0.00228	0.00368	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00226	0.00594	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—CD4—atopic dermatitis	0.00222	0.00586	CbGpPWpGaD
Framycetin—Infection—Fluocinonide—atopic dermatitis	0.00219	0.00353	CcSEcCtD
Framycetin—CXCR4—Hematopoietic Stem Cell Differentiation—IL6—atopic dermatitis	0.00218	0.00574	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CCL11—atopic dermatitis	0.00211	0.00555	CbGpPWpGaD
Framycetin—Glaucoma—Betamethasone—atopic dermatitis	0.00208	0.00335	CcSEcCtD
Framycetin—Glaucoma—Dexamethasone—atopic dermatitis	0.00208	0.00335	CcSEcCtD
Framycetin—Viral infection—Prednisolone—atopic dermatitis	0.00208	0.00334	CcSEcCtD
Framycetin—CXCR4—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.00205	0.00539	CbGpPWpGaD
Framycetin—Viral infection—Hydrocortisone—atopic dermatitis	0.00203	0.00327	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00201	0.0053	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00201	0.0053	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.002	0.00528	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00197	0.0052	CbGpPWpGaD
Framycetin—Pruritus—Desonide—atopic dermatitis	0.00193	0.00311	CcSEcCtD
Framycetin—Anaphylactic shock—Pimecrolimus—atopic dermatitis	0.00192	0.0031	CcSEcCtD
Framycetin—Infection—Pimecrolimus—atopic dermatitis	0.00191	0.00308	CcSEcCtD
Framycetin—CXCR4—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.00184	0.00486	CbGpPWpGaD
Framycetin—Glaucoma—Prednisone—atopic dermatitis	0.00181	0.00291	CcSEcCtD
Framycetin—CXCR4—G alpha (i) signalling events—CCL5—atopic dermatitis	0.00173	0.00455	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CCR3—atopic dermatitis	0.00172	0.00453	CbGpPWpGaD
Framycetin—Erythema—Fluocinolone Acetonide—atopic dermatitis	0.00169	0.00272	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—CCL22—atopic dermatitis	0.00168	0.00442	CbGpPWpGaD
Framycetin—CXCR4—HIV Infection—CCR5—atopic dermatitis	0.00166	0.00438	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CCL27—atopic dermatitis	0.00165	0.00434	CbGpPWpGaD
Framycetin—Hypersensitivity—Fluocinonide—atopic dermatitis	0.00163	0.00262	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.00159	0.0042	CbGpPWpGaD
Framycetin—Pruritus—Fluocinonide—atopic dermatitis	0.00156	0.00252	CcSEcCtD
Framycetin—CXCR4—G alpha (i) signalling events—CCR5—atopic dermatitis	0.00155	0.0041	CbGpPWpGaD
Framycetin—Anaphylactic shock—Loratadine—atopic dermatitis	0.00153	0.00247	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—NPS—atopic dermatitis	0.00153	0.00403	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—TAC1—atopic dermatitis	0.00153	0.00403	CbGpPWpGaD
Framycetin—CXCR4—HIV Life Cycle—CD4—atopic dermatitis	0.00151	0.00398	CbGpPWpGaD
Framycetin—Viral infection—Prednisone—atopic dermatitis	0.00151	0.00243	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—CXCR3—atopic dermatitis	0.0015	0.00396	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CCL27—atopic dermatitis	0.0015	0.00394	CbGpPWpGaD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.00144	0.0038	CbGpPWpGaD
Framycetin—Hypersensitivity—Pimecrolimus—atopic dermatitis	0.00142	0.00228	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.00137	0.00362	CbGpPWpGaD
Framycetin—Infection—Fluocinolone Acetonide—atopic dermatitis	0.00137	0.00221	CcSEcCtD
Framycetin—Diarrhoea—Dimenhydrinate—atopic dermatitis	0.00136	0.00219	CcSEcCtD
Framycetin—Diarrhoea—Diphenhydramine—atopic dermatitis	0.00136	0.00219	CcSEcCtD
Framycetin—Pruritus—Pimecrolimus—atopic dermatitis	0.00136	0.00219	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—CCL17—atopic dermatitis	0.00134	0.00354	CbGpPWpGaD
Framycetin—Diarrhoea—Pimecrolimus—atopic dermatitis	0.00132	0.00212	CcSEcCtD
Framycetin—Anaphylactic shock—Mometasone—atopic dermatitis	0.00132	0.00212	CcSEcCtD
Framycetin—Infection—Mometasone—atopic dermatitis	0.00131	0.00211	CcSEcCtD
Framycetin—Erythema—Tacrolimus—atopic dermatitis	0.00128	0.00207	CcSEcCtD
Framycetin—Vomiting—Dimenhydrinate—atopic dermatitis	0.00127	0.00204	CcSEcCtD
Framycetin—Vomiting—Diphenhydramine—atopic dermatitis	0.00127	0.00204	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.00124	0.00326	CbGpPWpGaD
Framycetin—Vomiting—Pimecrolimus—atopic dermatitis	0.00122	0.00197	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—CXCL10—atopic dermatitis	0.00121	0.0032	CbGpPWpGaD
Framycetin—CXCR4—Disease—GLB1—atopic dermatitis	0.0012	0.00317	CbGpPWpGaD
Framycetin—Nausea—Dimenhydrinate—atopic dermatitis	0.00118	0.0019	CcSEcCtD
Framycetin—Nausea—Diphenhydramine—atopic dermatitis	0.00118	0.0019	CcSEcCtD
Framycetin—Nausea—Pimecrolimus—atopic dermatitis	0.00114	0.00184	CcSEcCtD
Framycetin—CXCR4—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.00111	0.00294	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CCL11—atopic dermatitis	0.00108	0.00285	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FCER2—atopic dermatitis	0.00107	0.00281	CbGpPWpGaD
Framycetin—Diarrhoea—Loratadine—atopic dermatitis	0.00105	0.00169	CcSEcCtD
Framycetin—Anaphylactic shock—Tacrolimus—atopic dermatitis	0.00105	0.00169	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—CCL5—atopic dermatitis	0.00104	0.00275	CbGpPWpGaD
Framycetin—CXCR4—HIV Infection—CD4—atopic dermatitis	0.00104	0.00275	CbGpPWpGaD
Framycetin—Infection—Tacrolimus—atopic dermatitis	0.00104	0.00168	CcSEcCtD
Framycetin—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.00101	0.00164	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—CCL22—atopic dermatitis	0.000991	0.00261	CbGpPWpGaD
Framycetin—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.000975	0.00157	CcSEcCtD
Framycetin—Vomiting—Loratadine—atopic dermatitis	0.000975	0.00157	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—CCR3—atopic dermatitis	0.000971	0.00256	CbGpPWpGaD
Framycetin—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000943	0.00152	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—CCR5—atopic dermatitis	0.000941	0.00248	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.00094	0.00248	CbGpPWpGaD
Framycetin—Pruritus—Mometasone—atopic dermatitis	0.000931	0.0015	CcSEcCtD
Framycetin—Nausea—Loratadine—atopic dermatitis	0.00091	0.00147	CcSEcCtD
Framycetin—Diarrhoea—Mometasone—atopic dermatitis	0.0009	0.00145	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—CCL27—atopic dermatitis	0.000883	0.00233	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CCR3—atopic dermatitis	0.000881	0.00232	CbGpPWpGaD
Framycetin—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000876	0.00141	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—TAC1—atopic dermatitis	0.000865	0.00228	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—NPS—atopic dermatitis	0.000865	0.00228	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000848	0.00224	CbGpPWpGaD
Framycetin—Vomiting—Mometasone—atopic dermatitis	0.000836	0.00135	CcSEcCtD
Framycetin—Erythema—Prednisolone—atopic dermatitis	0.000819	0.00132	CcSEcCtD
Framycetin—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000818	0.00132	CcSEcCtD
Framycetin—CXCR4—Disease—SLC11A1—atopic dermatitis	0.000806	0.00213	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—IL5—atopic dermatitis	0.000804	0.00212	CbGpPWpGaD
Framycetin—Erythema—Hydrocortisone—atopic dermatitis	0.0008	0.00129	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—CCL17—atopic dermatitis	0.000792	0.00209	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—NPS—atopic dermatitis	0.000786	0.00207	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—TAC1—atopic dermatitis	0.000786	0.00207	CbGpPWpGaD
Framycetin—Nausea—Mometasone—atopic dermatitis	0.000781	0.00126	CcSEcCtD
Framycetin—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000771	0.00124	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—CXCR3—atopic dermatitis	0.00077	0.00203	CbGpPWpGaD
Framycetin—Erythema—Triamcinolone—atopic dermatitis	0.000753	0.00121	CcSEcCtD
Framycetin—Erythema—Methylprednisolone—atopic dermatitis	0.000752	0.00121	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000747	0.00197	CbGpPWpGaD
Framycetin—Pruritus—Tacrolimus—atopic dermatitis	0.000741	0.00119	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—IL5—atopic dermatitis	0.00073	0.00192	CbGpPWpGaD
Framycetin—Diarrhoea—Tacrolimus—atopic dermatitis	0.000716	0.00115	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—KIF3A—atopic dermatitis	0.000706	0.00186	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000686	0.00181	CbGpPWpGaD
Framycetin—Erythema—Dexamethasone—atopic dermatitis	0.000684	0.0011	CcSEcCtD
Framycetin—Erythema—Betamethasone—atopic dermatitis	0.000684	0.0011	CcSEcCtD
Framycetin—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000669	0.00108	CcSEcCtD
Framycetin—Vomiting—Tacrolimus—atopic dermatitis	0.000666	0.00107	CcSEcCtD
Framycetin—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000653	0.00105	CcSEcCtD
Framycetin—Infection—Hydrocortisone—atopic dermatitis	0.000649	0.00105	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—CCL11—atopic dermatitis	0.000639	0.00168	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CMA1—atopic dermatitis	0.000639	0.00168	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CXCL10—atopic dermatitis	0.000623	0.00164	CbGpPWpGaD
Framycetin—Nausea—Tacrolimus—atopic dermatitis	0.000622	0.001	CcSEcCtD
Framycetin—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000615	0.000991	CcSEcCtD
Framycetin—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000614	0.000989	CcSEcCtD
Framycetin—Infection—Triamcinolone—atopic dermatitis	0.000611	0.000984	CcSEcCtD
Framycetin—Infection—Methylprednisolone—atopic dermatitis	0.00061	0.000982	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—STAT6—atopic dermatitis	0.000601	0.00158	CbGpPWpGaD
Framycetin—Erythema—Prednisone—atopic dermatitis	0.000595	0.000959	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—CCL5—atopic dermatitis	0.00059	0.00156	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CXCL8—atopic dermatitis	0.000569	0.0015	CbGpPWpGaD
Framycetin—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000558	0.000899	CcSEcCtD
Framycetin—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000558	0.000899	CcSEcCtD
Framycetin—Infection—Betamethasone—atopic dermatitis	0.000554	0.000893	CcSEcCtD
Framycetin—Infection—Dexamethasone—atopic dermatitis	0.000554	0.000893	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—CCL5—atopic dermatitis	0.000536	0.00141	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CCR5—atopic dermatitis	0.000532	0.0014	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCR3—atopic dermatitis	0.000521	0.00137	CbGpPWpGaD
Framycetin—Hypersensitivity—Prednisolone—atopic dermatitis	0.000493	0.000794	CcSEcCtD
Framycetin—Anaphylactic shock—Prednisone—atopic dermatitis	0.000486	0.000783	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—CCR5—atopic dermatitis	0.000483	0.00127	CbGpPWpGaD
Framycetin—Infection—Prednisone—atopic dermatitis	0.000483	0.000778	CcSEcCtD
Framycetin—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000481	0.000775	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—TAC1—atopic dermatitis	0.000464	0.00122	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NPS—atopic dermatitis	0.000464	0.00122	CbGpPWpGaD
Framycetin—Pruritus—Hydrocortisone—atopic dermatitis	0.000462	0.000745	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—CXCR3—atopic dermatitis	0.000455	0.0012	CbGpPWpGaD
Framycetin—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000453	0.00073	CcSEcCtD
Framycetin—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000452	0.000728	CcSEcCtD
Framycetin—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000447	0.00072	CcSEcCtD
Framycetin—Pruritus—Triamcinolone—atopic dermatitis	0.000435	0.000701	CcSEcCtD
Framycetin—Pruritus—Methylprednisolone—atopic dermatitis	0.000434	0.000699	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—IL5—atopic dermatitis	0.000431	0.00114	CbGpPWpGaD
Framycetin—Diarrhoea—Methylprednisolone—atopic dermatitis	0.00042	0.000676	CcSEcCtD
Framycetin—Vomiting—Hydrocortisone—atopic dermatitis	0.000415	0.000669	CcSEcCtD
Framycetin—CXCR4—Disease—CCR5—atopic dermatitis	0.000407	0.00107	CbGpPWpGaD
Framycetin—Nausea—Prednisolone—atopic dermatitis	0.000397	0.00064	CcSEcCtD
Framycetin—Pruritus—Betamethasone—atopic dermatitis	0.000395	0.000636	CcSEcCtD
Framycetin—Pruritus—Dexamethasone—atopic dermatitis	0.000395	0.000636	CcSEcCtD
Framycetin—Vomiting—Triamcinolone—atopic dermatitis	0.000391	0.00063	CcSEcCtD
Framycetin—Vomiting—Methylprednisolone—atopic dermatitis	0.00039	0.000629	CcSEcCtD
Framycetin—Nausea—Hydrocortisone—atopic dermatitis	0.000388	0.000625	CcSEcCtD
Framycetin—Diarrhoea—Betamethasone—atopic dermatitis	0.000382	0.000615	CcSEcCtD
Framycetin—Diarrhoea—Dexamethasone—atopic dermatitis	0.000382	0.000615	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—CXCL10—atopic dermatitis	0.000368	0.00097	CbGpPWpGaD
Framycetin—Nausea—Triamcinolone—atopic dermatitis	0.000365	0.000589	CcSEcCtD
Framycetin—Nausea—Methylprednisolone—atopic dermatitis	0.000364	0.000587	CcSEcCtD
Framycetin—Hypersensitivity—Prednisone—atopic dermatitis	0.000358	0.000577	CcSEcCtD
Framycetin—Vomiting—Dexamethasone—atopic dermatitis	0.000355	0.000572	CcSEcCtD
Framycetin—Vomiting—Betamethasone—atopic dermatitis	0.000355	0.000572	CcSEcCtD
Framycetin—Pruritus—Prednisone—atopic dermatitis	0.000344	0.000554	CcSEcCtD
Framycetin—Diarrhoea—Prednisone—atopic dermatitis	0.000332	0.000536	CcSEcCtD
Framycetin—Nausea—Dexamethasone—atopic dermatitis	0.000331	0.000534	CcSEcCtD
Framycetin—Nausea—Betamethasone—atopic dermatitis	0.000331	0.000534	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000322	0.000847	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCL5—atopic dermatitis	0.000317	0.000835	CbGpPWpGaD
Framycetin—Vomiting—Prednisone—atopic dermatitis	0.000309	0.000498	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—IL2—atopic dermatitis	0.000307	0.00081	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NGF—atopic dermatitis	0.000293	0.000773	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CXCL8—atopic dermatitis	0.000292	0.00077	CbGpPWpGaD
Framycetin—Nausea—Prednisone—atopic dermatitis	0.000289	0.000465	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—CCR5—atopic dermatitis	0.000285	0.000752	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—IL2—atopic dermatitis	0.000279	0.000735	CbGpPWpGaD
Framycetin—CXCR4—Disease—CD4—atopic dermatitis	0.000256	0.000674	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NFKBIA—atopic dermatitis	0.000242	0.000637	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CXCL8—atopic dermatitis	0.000172	0.000455	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IL2—atopic dermatitis	0.000165	0.000434	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—IL6—atopic dermatitis	0.000164	0.000432	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MAPK8—atopic dermatitis	0.000152	0.0004	CbGpPWpGaD
Framycetin—CXCR4—Disease—IL6—atopic dermatitis	0.000138	0.000365	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IL6—atopic dermatitis	9.69e-05	0.000255	CbGpPWpGaD
